1 Departments of Medicine, Harvard Medical School and Joslin Diabetes Foundation, Inc., and the Departments of Pathology, Harvard Medical School and Boston Hospital for Women, Lying-in Division, Boston
Serum insulin and glucose measurements were performed soon after birth in 12 infants with erythroblastosis fetalis (EBF) and 14 normal neonates. In addition, in eight infants with EBF, insulin levels were determined at birth and again prior to exchange transfusion. Significant elevation of serum immunoreactive insulin (29.6 ± 5.1 versus 10.1 ± 2.2 µU/ml, mean ± SEM) was found in the EBF group and was not related to bilirubin levels or hematocrits. Comparison between immunoreactive insulin level at birth and prior to exchange transfusion showed no difference. The possibility of predisposition to hypoglycemia in EBF should lead to frequent monitoring of blood glucose and appropriate measures to prevent or treat this complication.
Submitted on July 1, 1968
This article has been cited by other articles:
![]() |
F. FALLUCCA, A. SABBATINI, N. DI BIASE, E. BORRELLO, A. NAPOLI, and E. SCIULLO Fetal Pancreatic Function in Infants of Diabetic and Rhesus-Isoimmunized Women Obstet. Gynecol., February 1, 2000; 95(2): 195 - 198. [Abstract] [Full Text] [PDF] |
||||